Development of hypertriglyceridemia in patients with enterocutaneous fistulas

Clinical Nutrition

Volumn 28, Issue 3, 2009, Pages 313-317

  Visschers, Ruben G J ^a,b   Olde Damink, Steven W M ^a,b,c   Schreurs, Malou ^b   Winkens, Bjorn ^d   Soeters, Peter B ^a,b   van Gemert, Wim G ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Enterocutaneous fistulas; Hypertriglyceridemia; Parenteral nutrition; Sepsis; Short bowel syndrome; Triglycerides

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; ENTERITIS; ENTEROCUTANEOUS FISTULA; FEMALE; HAZARD RATIO; HEALTH STATUS; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATORY DISEASE; INTESTINE FISTULA; MALE; MULTIVARIATE ANALYSIS; NEOPLASM; PARENTERAL NUTRITION; PROPORTIONAL HAZARDS MODEL; SEPSIS; TRIACYLGLYCEROL BLOOD LEVEL;

FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INTESTINAL FISTULA; INTESTINE, SMALL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARENTERAL NUTRITION; PROPORTIONAL HAZARDS MODELS; SEPSIS; TRIGLYCERIDES;

EID: 67349284837     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.03.001     Document Type: Article

References (30)

1. Visschers R.G., Olde Damink S.W., Winkens B., Soeters P.B., and van Gemert W.G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 32 3 (2008) 445-453
2. Mawdsley J.E., Hollington P., Bassett P., Windsor A.J., Forbes A., and Gabe S.M. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. Aliment Pharmacol Ther 28 9 (2008) 1111-1121
3. Llop J., Sabin P., Garau M., Burgos R., Perez M., Masso J., et al. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 22 6 (2003) 577-583
4. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94 6 (1997) 2557-2562
5. Versleijen M.W., Oyen W.J., Roelofs H.M., van Emst-de Vries S.E., Willems P.H., Jansen J.B., et al. Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study. Am J Clin Nutr 87 3 (2008) 539-547
6. Venus B., Prager R., Patel C.B., Sandoval E., Sloan P., and Smith R.A. Cardiopulmonary effects of intralipid infusion in critically ill patients. Crit Care Med 16 6 (1988) 587-590
7. Koruk M., Savas M.C., Yilmaz O., Taysi S., Karakok M., Gundogdu C., et al. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 37 2 (2003) 177-182
8. Alvarez C., and Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 32 1 Pt 1 (1986) 142-145
9. Lanza-Jacoby S., Phetteplace H., Sedkova N., and Knee G. Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia. Shock 9 1 (1998) 46-51
10. Clark J.A., and Coopersmith C.M. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28 4 (2007) 384-393
11. Nonogaki K., Fuller G.M., Fuentes N.L., Moser A.H., Staprans I., Grunfeld C., et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136 5 (1995) 2143-2149
12. Dudrick S.J., Maharaj A.R., and McKelvey A.A. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 23 6 (1999) 570-576
13. Nestel P.J., and Barter P.J. Triglyceride clearance during diets rich in carbohydrate or fats. Am J Clin Nutr 26 3 (1973) 241-245
14. Nordenstrom J., Carpentier Y.A., Askanazi J., Robin A.P., Elwyn D.H., Hensle T.W., et al. Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 196 2 (1982) 221-231
15. Aarsland A., Chinkes D., and Wolfe R.R. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98 9 (1996) 2008-2017
16. Beau P., Meyran E., Chassin J., and Matuchansky C. Cyclic parenteral nutrition in hospitalized adult patients: a 9-year experience. Clin Nutr 13 1 (1994) 22-28
17. Johnson R.C., Young S.K., Cotter R., Lin L., and Rowe W.B. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr 52 3 (1990) 502-508
18. Wang H., Khaoustov V.I., Krishnan B., Cai W., Stoll B., Burrin D.G., et al. Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets. J Nutr 136 10 (2006) 2547-2552
19. Wanten G.J., and Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85 5 (2007) 1171-1184
20. Martin C.R., Dumas G.J., Shoaie C., Zheng Z., Mackinnon B., Al-Aweel I., et al. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: a retrospective analysis. J Pediatr 152 2 (2008) 232-236
21. Morris S., Simmer K., and Gibson R. Utilization of docosahexaenoic acid from intravenous egg yolk phospholipid. Lipids 35 4 (2000) 383-388
22. Driscoll D.F., Ling P.R., Quist W.C., and Bistrian B.R. Pathological consequences from the infusion of unstable lipid emulsion admixtures in guinea pigs. Clin Nutr 24 1 (2005) 105-113
23. Soeters P.B., Luyer M.D., Greve J.W., and Buurman W.A. The significance of bowel permeability. Curr Opin Clin Nutr Metab Care 10 5 (2007) 632-638
24. Akerlund J.E., Bjorkhem I., Angelin B., Liljeqvist L., and Einarsson K. Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism. Gut 35 8 (1994) 1116-1120
25. Farkkila M.A., Tilvis R.S., and Miettinen T.A. Raised plasma cholesterol precursors in patients with gut resections. Gut 29 2 (1988) 188-195
26. Kimmings A.N., van Deventer S.J., Obertop H., and Gouma D.J. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats. J Am Coll Surg 189 4 (1999) 374-379
27. Pappo I., Becovier H., Berry E.M., and Freund H.R. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 51 2 (1991) 106-112
28. Rinsema W., Gouma D.J., von Meyenfeldt M.F., and Soeters P.B. Reinfusion of secretions from high-output proximal stomas or fistulas. Surg Gynecol Obstet 167 5 (1988) 372-376
29. Diehl A.M., Li Z.P., Lin H.Z., and Yang S.Q. Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut 54 2 (2005) 303-306
30. MacFaul G.R., and Chapman R.W. Sclerosing cholangitis. Curr Opin Gastroenterol 22 3 (2006) 288-293